Mwanzo8QQ • FRA
AbCellera Biologics Inc
€ 2.34
30 Sep, 18:16:23 GMT +2 · EUR · FRA · Kanusho
HisaHisa zinazouzwa DEMakao yake makuu ni CA
Bei iliyotangulia
€ 2.30
Bei za siku
€ 2.31 - € 2.34
Bei za mwaka
€ 2.17 - € 5.43
Thamani ya kampuni katika soko
813.47M USD
Wastani wa hisa zilizouzwa
159.00
Uwiano wa bei na mapato
-
Mgao wa faida
-
Ubadilishanaji wa msingi
NASDAQ
Habari za soko
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
(USD)Jun 2024Mabadiliko Tangu Mwaka Uliopita
Mapato
7.32M-27.18%
Matumizi ya uendeshaji wa biashara
59.85M139.67%
Mapato halisi
-36.93M-20.97%
Kiwango cha faida halisi
-504.30-66.12%
Mapato kwa kila hisa
-0.13-18.18%
EBITDA
-56.93M-24.36%
Asilimia ya kodi ya mapato
23.36%
Jumla ya mali
Jumla ya dhima
(USD)Jun 2024Mabadiliko Tangu Mwaka Uliopita
Uwekezaji wa pesa taslimu na vipindi vifupi
670.36M-15.75%
Jumla ya mali
1.41B-8.11%
Jumla ya dhima
301.51M-11.93%
Jumla ya hisa
1.11B
hisa zilizosalia
294.67M
Uwiano wa bei na thamani
0.61
Faida inayotokana na mali
-16.25%
Faida inayotokana mtaji
-19.58%
Mabadiliko halisi ya pesa taslimu
(USD)Jun 2024Mabadiliko Tangu Mwaka Uliopita
Mapato halisi
-36.93M-20.97%
Pesa kutokana na shughuli
-29.97M-250.56%
Pesa kutokana na uwekezaji
52.10M251.49%
Pesa kutokana na ufadhili
2.65M532.70%
Mabadiliko halisi ya pesa taslimu
24.74M286.42%
Mtiririko huru wa pesa
-42.55M-1,686.49%
Kuhusu
AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology firm that researches and develops human antibodies. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia. Wikipedia
Afisa Mkuu Mtendaji (CEO)
Ilianzishwa
2012
Wafanyakazi
586
Tafuta
Futa utafutaji
Funga kisanduku cha kutafutia
Programu za Google
Menyu kuu